US 11,940,360 B2
Biological sample treatment apparatus
Mark Brian Dockrill, Chadstone (AU); and Samuel Gason, Malvern East (AU)
Assigned to LEICA BIOSYSTEMS MELBOURNE PTY LTD, Mount Waverley (AU)
Filed by LEICA BIOSYSTEMS MELBOURNE PTY LTD, Mount Waverley (AU)
Filed on Jun. 7, 2021, as Appl. No. 17/340,356.
Application 16/035,848 is a division of application No. 14/358,375, granted, now 10,036,690, issued on Jul. 31, 2018, previously published as PCT/AU2012/001415, filed on Nov. 15, 2012.
Application 17/340,356 is a continuation of application No. 16/035,848, filed on Jul. 16, 2018, granted, now 11,060,957.
Claims priority of provisional application 61/560,569, filed on Nov. 16, 2011.
Prior Publication US 2021/0293670 A1, Sep. 23, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. G01N 1/31 (2006.01); G01N 35/00 (2006.01)
CPC G01N 1/31 (2013.01) [G01N 1/312 (2013.01); G01N 35/00029 (2013.01); G01N 2035/00079 (2013.01)] 11 Claims
 
1. An apparatus for treating biological samples disposed on substrates, including:
an input buffer for receiving one or more substrate holders each being adapted to support a plurality of the substrates;
a treatment zone including a plurality of treatment stations each being adapted to receive one of the substrates;
a reagent dispenser configured by a controller to dispense reagents to the substrates at the treatment stations;
a substrate transport device configured by the controller to transport individual substrates between the substrate holders in the input buffer and the treatment stations, wherein the controller is configured to cause the substrate transport device to group individual substrates within the treatment zone to treat the biological samples disposed on substrates; and
wherein the controller is configured to cause the substrate transport device to group individual substrates to which a common reagent is to be applied.